- Event

Asceneuron to present at the 17th International Conference on Alzheimer’s Drug Discovery on 12-13 September, 2016 in Jersey City, NJ, USA

Dr. Beher, CEO will lecture on O-GlcNAcase Inhibitors for Tauopathies.

The International Conference on Alzheimer’s Drug Discovery brings together academic and industry scientists intent on accelerating the development of innovative treatments for Alzheimer’s disease and related dementias. The ADDF's funded investigators and top-level scientists in the field will present on their current research progress and stimulate discussion.

More about this event